Funding: Omada Health, Crittercism, and Quora can now fund international expansion and product improvement.



As, a unique must-attend landmark when it comes to the end-to-end digital’s transformation, Connectikpeople.co, recalls that, this rubric is intended to help organizations, and investors to live in real-time what happens in the startups world; in terms of funding, acquisitions, strategic alliances and more. Regarding the emerging countries, and startups, this is an instrument for them to discover which Venture Capital or Business angel can fund their
projects.

Omada Health ( founded in 2011, San Francisco-based digital diabetes prevention program), has raised $23 million in a Series B round led by Andreessen Horowitz with participation from Kaiser Permanente Ventures and previous investors U.S. Venture Partners and The Vertical Group. Connectikpeople.co recalls that, Omada Health creates digital health therapy programs that are covered by insurance providers. Omada will put the funds toward product development and doubling its headcount by the end of the year.

Crittercism ( Founded in 2011, San Francisco-based mobile app performance management solution) has raised $30 million in a Series C funding led by Scale Venture Partners with participation from InterWest Partners, VMware, and Accenture. With Crittercism companies can monitor mobile app performance getting a real-time global view of app diagnostics. Crittercism will use the new funds to invest in enterprise initiatives and expand its presence in South America, Europe, and Asia-Pacific.

Quora ( founded in 2009, Mountain View-based Q&A site), has raised $80 million in a Series C funding led by Tiger Global with participation from existing investors Benchmark, Matrix, Northbridge, and Peter Thiel. If unfamiliar, Connectikpeople.co recalls that, Quora is a collection of questions and answers created, edited, and organized by its users. Quora has raised over $150 to date and will use the new cash to fund international expansion and product improvement.

Popular Posts